Articles for category: Most Popular

Dynatrace Benefits From AI, Cloud and Telemetry Trends

Dynatrace DT is benefiting from several themes shaping enterprise software spending, including artificial intelligence, cloud complexity, platform consolidation and rising telemetry volumes. The opportunity is clear, but not risk-free. Higher consumption can lift demand while also raising hosting costs, and DT still has to convert usage growth into annual recurring revenue and profit expansion. Dynatrace ...

Nervous About AI Spending? Buy the Stocks of These 3 Tech Giants.

Key Points Nvidia has driven massive growth despite spending little on capital expenditures. Despite challenges, Microsoft’s AI continues to deliver robust growth. Meta’s existing businesses continue to grow rapidly and have helped to foster its AI transformation. 10 stocks we like better than Nvidia › The sheer amount of capital expenditures (capex) spending on artificial ...

Advanced Micro Devices vs. Nvidia: What Revenue Growth Rates and Scale Reveal for Investors

Key Points Nvidia currently generates higher overall revenue, maintaining a substantial and rapidly expanding absolute scale advantage over Advanced Micro Devices. Nvidia has experienced consistent, rapid quarter-over-quarter revenue expansion, while Advanced Micro Devices has shown a much slower, relatively stable revenue trajectory over the same eight-quarter period. Investors should carefully watch whether the widening revenue ...

If I Had $10,000 to Invest Today, Here's the Trillion-Dollar Stock I'd Buy Instead of SpaceX

Key Points Space Exploration Technologies went public last month, and it’s already in the throes of a sell-off. SpaceX stock is still extremely expensive, so investors can probably find better values elsewhere. Nvidia supplies the best data center chips for artificial intelligence workloads, and its stock is trading at a very attractive valuation. 10 stocks ...

BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?

bioAffinity Technologies, Inc.’s BIAF investors have been experiencing some short-term losses. Shares of the San Antonio, TX-based biotechnology company have lost 77% in the past three months against the industry’s 4.5% rise. It has also underperformed the sector and the S&P 500’s gain of 8.2% and 10.1%, respectively, in the same time frame. Two major ...

UiPath's Valuation Looks Attractive After the Recent Pullback

UiPath’s PATH recent share price pullback has made its valuation more compelling, particularly for long-term investors. Despite improving financial performance and stronger demand for its automation platform, the stock trades at a more reasonable forward earnings multiple than it did during its earlier rally. This disconnect suggests that much of the market’s caution surrounding AI-related ...

The Iranian Ceasefire Collapses: What Happens Now?

Listen to the audio version of this article (generated by AI). The Middle East ceasefire breaks down… Luke Lango says corrections are a feature, not a bug… his gameplan for where to buy… a contrarian 14% Bitcoin play from Jonathan Rose… As I write on Wednesday, the ceasefire between the U.S. and Iran is over. ...

Is Netflix (NFLX) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Let’s take a look at what these Wall Street heavyweights have to say about Netflix (NFLX) before we ...